Trust the (cell manufacturing) process: Turning Research into ATMP in Flemingsberg!

Are you a practicing scientist from academia and/or industry, or simply interested in advanced therapies? We at the Flemingsberg Science Foundation warmly welcome you to the most important ATMP event of the spring!

When? March 21st
Where? Svartsjön room, Novum building, Campus Flemingsberg
Hälsovägen 7, 141 57 Huddinge

Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, getting new Advanced Therapy Medicinal Products (ATMPs) from the research lab to the reality of the patient bedside, relies not only on a robust and scalable cell manufacturing process, but also on successful navigation of the regulatory environment and an engaged and supportive ATMP community.

As stakeholders with a shared vision of creating momentum in accelerating access to ATMPs in the Nordics, Flemingsberg Science Foundation, Karolinska ATMP-centrum and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in getting new ATMPs from concept to clinic. Join Nordic cell therapy experts and enthusiasts in uniting towards bringing more ATMP options to more patients, more efficiently.

Welcome!

Speakers:
Johnny Högberg
Matti Sallberg
Pontus Blomberg
Stephan Mielke
Gustaf Ahlén
Di Yu
Stina Wickström
Nikola Vojnovic

Register here

Partners
Karolinska Universitetssjukhuset
Karolinska Institutet
Miltenyi Biotec
Elicera Therapeutics AB
ATMP Sweden

Published On: 8 February 2024

  • National conference with a focus on ATMP

    The national conference ATMP Sweden 2022 Stockholm takes place on 7-8 November. The conference begins with a half-day of seminar and study visit in Flemingsberg.

  • Lab facilities where businesses can grow

    A Working Lab, (AWL), has now opened its doors in Flemingsberg. The site offers generous lab spaces in various sizes to help more businesses grow in a vibrant life science environment.

  • Elicera Therapeutics develops new cancer treatment with help of advanced cell lab in Flemingsberg

    Uppsala-based Elicera Therapeutics is using the Pre-GMP core facility at Vecura in Flemingsberg as a first step in a study aimed at creating a new treatment for lymph node cancer.

  • Flemingsberg set to become home to Alfa Laval’s future innovations

    The opening of Alfa Laval’s new development and innovation centre in Flemingsberg in 2025 will also see the launch of an exciting new technology. Ground was recently broken for the centre, which will accommodate around 700 employees.

  • EU’s first innovation hub to be run from Flemingsberg

    Health Data Sweden (HDS) will be the first among the EU’s new digital innovation hubs. The initiative is managed by Sebastiaan Meijer, Deputy Head of School at KTH in Flemingsberg.